Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bessone

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2024
Secondary Sclerosing Cholangitis due to Drugs With a Special Emphasis on Checkpoint InhibitorsEinar S Bjornsson, Daiana Arnedillo, Fernando Bessone
World Journal of Hepatology|July 15, 2014
Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesisFernando Bessone, Natalia Poles, Marcelo G Roma
Current Drug Safety|February 16, 2019
Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing ScenarioCarla Stefania Colaci, Manuel Mendizabal, Fernando Bessone
Cellular and Molecular Life Sciences : CMLS|October 22, 2018
Molecular pathways of nonalcoholic fatty liver disease development and progressionFernando Bessone, María Valeria Razori, Marcelo G Roma
Seminars in Liver Disease|June 15, 2021
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and TherapeuticsFernando Bessone, Nelia Hernández, Mario Tanno, et al.
International Journal of Molecular Sciences|March 4, 2016
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic InitiativeFernando Bessone, Nelia Hernandez, M Isabel Lucena, et al.
Journal of Clinical and Translational Hepatology|February 7, 2025
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic MechanismsFernando Bessone, Geraldine L Hillotte, Norberto Tamagnone, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2018
Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated viewFernando Bessone, Melisa Dirchwolf, María Agustina Rodil, et al.
Seminars in Liver Disease|February 20, 2024
UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological BasisFernando Bessone, Geraldine L Hillotte, Natalia Ahumada, et al.
Seminars in Liver Disease|May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical PracticeFernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2024
Secondary Sclerosing Cholangitis due to Drugs With a Special Emphasis on Checkpoint InhibitorsEinar S Bjornsson, Daiana Arnedillo, Fernando Bessone
World Journal of Hepatology|July 15, 2014
Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesisFernando Bessone, Natalia Poles, Marcelo G Roma
Current Drug Safety|February 16, 2019
Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing ScenarioCarla Stefania Colaci, Manuel Mendizabal, Fernando Bessone
Cellular and Molecular Life Sciences : CMLS|October 22, 2018
Molecular pathways of nonalcoholic fatty liver disease development and progressionFernando Bessone, María Valeria Razori, Marcelo G Roma
Seminars in Liver Disease|June 15, 2021
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and TherapeuticsFernando Bessone, Nelia Hernández, Mario Tanno, et al.
International Journal of Molecular Sciences|March 4, 2016
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic InitiativeFernando Bessone, Nelia Hernandez, M Isabel Lucena, et al.
Journal of Clinical and Translational Hepatology|February 7, 2025
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic MechanismsFernando Bessone, Geraldine L Hillotte, Norberto Tamagnone, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2018
Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated viewFernando Bessone, Melisa Dirchwolf, María Agustina Rodil, et al.
Seminars in Liver Disease|February 20, 2024
UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological BasisFernando Bessone, Geraldine L Hillotte, Natalia Ahumada, et al.
Seminars in Liver Disease|May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical PracticeFernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
Pageof 8